16 November 2023
On November 14th, 2023, Thermo Fisher Scientific Inc. (NYSE: TMO) announced that its Board of Directors has authorized the repurchase of $4 billion of shares of its common stock in the open market or in negotiated transactions.
The authorization has no expiration date.
The authorization replaces company’s existing share buyback program, of which $1 billion was remaining.
Etalon Capital, Inc. provides independent research with a focus on event-driven value equities to institutional investors. Events include M&As, spin-offs, activist investors, IPOs, SPACs, buybacks, recapitalizations, asset sales, hedge fund holdings, and other significant corporate transactions. These are diversified by sources of risk as well as risk/return profiles. We generate an edge with a unique research process, combining value, focus on corporate events, and story investing principles.